What is Toothsi?
Toothsi operates at the intersection of dental health and consumer technology, providing a sophisticated, at-home solution for teeth straightening. By offering clear aligners that are both BPA-free and FDA-approved, the company provides a scientific, cost-effective alternative to traditional braces. Its market position is defined by a commitment to accessibility and convenience, effectively lowering the barrier to entry for orthodontic treatment. Through a digital-first approach, Toothsi has successfully captured a significant share of the aesthetic dentistry market, appealing to consumers who prioritize both efficacy and affordability in their healthcare choices.
How much funding has Toothsi raised?
Toothsi has raised a total of $74M across 4 funding rounds:
Series A
$5M
Series B
$20M
Unspecified
$9M
Series C
$40M
Series A (2021): $5M with participation from Think Investments
Series B (2021): $20M led by Think Investments, Eight Roads, and Mankekar Family Office
Unspecified (2022): $9M supported by Stride Ventures
Series C (2022): $40M featuring IIFL, Eight Roads, and Paramark
Key Investors in Toothsi
Eight Roads
Eight Roads is a global venture capital firm with a focus on supporting high-growth businesses across the real estate and technology sectors.
Stride Ventures
Stride Ventures is a New Delhi-based venture capital firm dedicated to providing strategic financing to innovative startups across the Indian market.
Think Investments
Think Investments is an institutional investment firm that provides long-term capital to companies demonstrating significant market disruption potential.
What's next for Toothsi?
With the recent infusion of capital, Toothsi is well-positioned to scale its enterprise-level operations and further penetrate the competitive dental technology landscape. The strategic focus will likely shift toward enhancing its proprietary alignment technology, expanding its geographic footprint, and optimizing its supply chain to maintain its competitive pricing advantage. As the company matures, the emphasis will remain on operational excellence and the continued integration of data-driven insights to improve patient outcomes. Investors will be closely monitoring the firm's ability to maintain its growth momentum while navigating the complexities of the broader health-tech ecosystem.
See full Toothsi company page
